These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
708 related items for PubMed ID: 2525062
21. AMPA/kainate antagonists in the nucleus accumbens inhibit locomotor stimulatory response to cocaine and dopamine agonists. Kaddis FG, Wallace LJ, Uretsky NJ. Pharmacol Biochem Behav; 1993 Nov; 46(3):703-8. PubMed ID: 7506423 [Abstract] [Full Text] [Related]
22. The role of endogenous dopamine in the hypermotility response to intra-accumbens AMPA. Boldry RC, Willins DL, Wallace LJ, Uretsky NJ. Brain Res; 1991 Sep 13; 559(1):100-8. PubMed ID: 1685936 [Abstract] [Full Text] [Related]
23. Hippocampal modulation of locomotor activity induced by focal activation of postsynaptic dopamine receptors in the core of the nucleus accumbens. Rouillon C, Abraini JH, David HN. Hippocampus; 2007 Sep 13; 17(11):1028-36. PubMed ID: 17604350 [Abstract] [Full Text] [Related]
24. Is stimulation of both D1 and D2 receptors necessary for the expression of dopamine-mediated behaviors? White FJ, Bednarz LM, Wachtel SR, Hjorth S, Brooderson RJ. Pharmacol Biochem Behav; 1988 May 13; 30(1):189-93. PubMed ID: 2902644 [Abstract] [Full Text] [Related]
25. Behavioural stimulation is induced by separate dopamine D-1 and D-2 receptor sites in reserpine-pretreated but not in normal rats. Arnt J. Eur J Pharmacol; 1985 Jul 11; 113(1):79-88. PubMed ID: 2931283 [Abstract] [Full Text] [Related]
26. Reevaluation of the two-component hypothesis for turning behaviour by manipulating activities in the striatum and the nucleus accumbens of intact rats. Saigusa T, Koshikawa N, Kitamura M, Kobayashi M. Eur J Pharmacol; 1993 Jun 24; 237(2-3):161-8. PubMed ID: 8103458 [Abstract] [Full Text] [Related]
27. Pharmacological characterization of the receptor mediating electrophysiological responses to dopamine in the rat medial prefrontal cortex: a microiontophoretic study. Sesack SR, Bunney BS. J Pharmacol Exp Ther; 1989 Mar 24; 248(3):1323-33. PubMed ID: 2564893 [Abstract] [Full Text] [Related]
28. The actions of (-)N-n-propylnorapomorphine and selective dopamine D1 and D2 receptor agonists to modify the release of [3H]dopamine from the rat nucleus accumbens. Barnes JM, Barnes NM, Costall B, Naylor RJ. Neuropharmacology; 1990 Apr 24; 29(4):327-36. PubMed ID: 1971430 [Abstract] [Full Text] [Related]
29. Mesoaccumbens dopamine-opiate interactions in the control over behaviour by a conditioned reinforcer. Phillips GD, Robbins TW, Everitt BJ. Psychopharmacology (Berl); 1994 Mar 24; 114(2):345-59. PubMed ID: 7838928 [Abstract] [Full Text] [Related]
31. B-HT 920 stimulates postsynaptic D2 dopamine receptors in the normal rat: electrophysiological and behavioral evidence. Johansen PA, Clarkl D, White FJ. Life Sci; 1988 Mar 24; 43(6):515-24. PubMed ID: 2900459 [Abstract] [Full Text] [Related]
32. Modulation of acetylcholine release by D1, D2 dopamine receptors in rat striatum under freely moving conditions. Ajima A, Yamaguchi T, Kato T. Brain Res; 1990 Jun 04; 518(1-2):193-8. PubMed ID: 1975213 [Abstract] [Full Text] [Related]
33. Role of the substantia nigra in the expression of dopamine D1 receptor-mediated and D2 receptor-mediated behaviours. Fletcher GH, Starr MS. Neuroscience; 1987 Dec 04; 23(3):1001-10. PubMed ID: 2963970 [Abstract] [Full Text] [Related]
34. Behavioural effects of 7-OH-DPAT are solely due to stimulation of dopamine D2 receptors in the shell of the nucleus accumbens; turning behaviour. Koshikawa N, Kitamura M, Kobayashi M, Cools AR. Eur J Pharmacol; 1996 Jul 25; 308(3):235-41. PubMed ID: 8858293 [Abstract] [Full Text] [Related]
35. Enhanced behavioral stereotypies elicited by intrastriatal injection D1 and D2 dopamine agonists in intact rats. Bordi F, Meller E. Brain Res; 1989 Dec 18; 504(2):276-83. PubMed ID: 2574622 [Abstract] [Full Text] [Related]
36. Hemispheric asymmetry in behavioral response to D1 and D2 receptor agonists in the nucleus accumbens. Belcheva I, Bryer JB, Starkstein SE, Honig M, Moran TH, Robinson RG. Brain Res; 1990 Nov 19; 533(2):286-91. PubMed ID: 1981170 [Abstract] [Full Text] [Related]
38. Place conditioning with dopamine D1 and D2 agonists injected peripherally or into nucleus accumbens. White NM, Packard MG, Hiroi N. Psychopharmacology (Berl); 1991 Nov 19; 103(2):271-6. PubMed ID: 1674160 [Abstract] [Full Text] [Related]
39. Role of N-methyl-D-aspartate receptors in dopamine D1-, but not D2-, mediated changes in striatal and accumbens neurotensin systems. Singh NA, Bush LG, Gibb JW, Hanson GR. Brain Res; 1992 Feb 07; 571(2):260-4. PubMed ID: 1351780 [Abstract] [Full Text] [Related]
40. Supraspinal D2 receptor involved in antinociception induced by l-tetrahydropalmatine. Hu JY, Jin GZ. Zhongguo Yao Li Xue Bao; 1999 Aug 07; 20(8):715-9. PubMed ID: 10678104 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]